1. Wan, Zhen, Wang, Xuzhen. 2022. Role of SLC39A6 in the development and progression of liver cancer. In Oncology letters, 23, 77. doi:10.3892/ol.2022.13197. https://pubmed.ncbi.nlm.nih.gov/35111246/
2. Cui, Xiao-Bin, Shen, Yao-Yuan, Jin, Ting-Ting, Chen, Yun-Zhao, Li, Feng. 2015. SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma. In Journal of translational medicine, 13, 321. doi:10.1186/s12967-015-0681-z. https://pubmed.ncbi.nlm.nih.gov/26444413/
3. Zhao, Lei, Tan, Jiaqi, Li, Dan, Wang, Jue, Zhou, Jianfeng. 2019. SLC39A6/ZIP6 is essential for zinc homeostasis and T-cell development in zebrafish. In Biochemical and biophysical research communications, 511, 896-902. doi:10.1016/j.bbrc.2019.02.148. https://pubmed.ncbi.nlm.nih.gov/30851936/
4. Althobiti, Maryam, El-Sharawy, Khloud A, Joseph, Chitra, Green, Andrew R, Rakha, Emad A. 2021. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer. In Breast cancer research and treatment, 189, 621-630. doi:10.1007/s10549-021-06336-y. https://pubmed.ncbi.nlm.nih.gov/34453638/
5. Gao, Jian, Ren, Wenjun, Xiao, Chunhong, Lin, Liying, Chen, Shaoquan. 2019. Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection. In BMC cancer, 19, 1069. doi:10.1186/s12885-019-6222-z. https://pubmed.ncbi.nlm.nih.gov/31703635/